Related Experiment Video
Updated: May 22, 2026

Prostate Organoid Cultures as Tools to Translate Genotypes and Mutational Profiles to Pharmacological Responses
Published on: October 24, 2019
A transcriptional repressor co-regulatory network governing androgen response in prostate cancers
Kern Rei Chng1, Cheng Wei Chang, Si Kee Tan
1Cancer Biology and Pharmacology, Genome Institute of Singapore, A*STAR, Singapore.
Abstract:
Transcriptional corepressors are frequently aberrantly over-expressed in prostate cancers. However, their crosstalk with the Androgen receptor (AR), a key player in prostate cancer development, is unclear. Using ChIP-Seq, we generated extensive global binding maps of AR, ERG, and commonly over-expressed transcriptional corepressors including HDAC1, HDAC2, HDAC3, and EZH2 in prostate cancer cells. Surprisingly, our results revealed that ERG, HDACs, and EZH2 are directly involved in androgen-regulated transcription and wired into an AR centric transcriptional network via a spectrum of distal enhancers and/or proximal promoters. Moreover, we showed that similar to ERG, these corepressors function to mediate repression of AR-induced transcription including cytoskeletal genes that promote epithelial differentiation and inhibit metastasis. Specifically, we demonstrated that the direct suppression of Vinculin expression by ERG, EZH2, and HDACs leads to enhanced invasiveness of prostate cancer cells. Taken together, our results highlight a novel mechanism by which, ERG working together with oncogenic corepressors including HDACs and the polycomb protein, EZH2, could impede epithelial differentiation and contribute to prostate cancer progression, through directly modulating the transcriptional output of AR.
Insights
Oncogenic corepressors like HDACs and EZH2, alongside ERG, directly repress Androgen Receptor (AR) target genes. This mechanism promotes prostate cancer progression by hindering differentiation and increasing cell invasiveness.
Area of Science:
- Molecular Oncology
- Cancer Biology
- Epigenetics
Background:
- Transcriptional corepressors are often over-expressed in prostate cancer.
- The interaction between corepressors and the Androgen Receptor (AR) in prostate cancer is not well understood.
Purpose of the Study:
- To investigate the crosstalk between AR and key transcriptional corepressors (HDAC1, HDAC2, HDAC3, EZH2) in prostate cancer.
- To elucidate the role of these corepressors and ERG in AR-regulated transcription and prostate cancer progression.
Main Methods:
- Chromatin immunoprecipitation followed by sequencing (ChIP-Seq) was used to map the binding sites of AR, ERG, HDAC1, HDAC2, HDAC3, and EZH2.
- Analysis of global binding patterns in prostate cancer cells.
Main Results:
- ERG, HDACs, and EZH2 are directly involved in androgen-regulated transcription, forming an AR-centric network.
- These corepressors mediate the repression of AR-induced genes, including those involved in epithelial differentiation and metastasis suppression.
- Suppression of Vinculin expression by ERG, EZH2, and HDACs correlates with increased prostate cancer cell invasiveness.
Conclusions:
- ERG, in conjunction with oncogenic corepressors (HDACs, EZH2), impedes epithelial differentiation.
- This interaction contributes to prostate cancer progression by modulating AR transcriptional output and enhancing cell invasiveness.
More Related Videos
12:13Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
Published on: November 19, 2019
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
Related Concept Videos
Co-activators and Co-repressors
Co-activators and Co-repressors
Master Transcription Regulators
Master Transcription Regulators
RNA Polymerase II Accessory Proteins
Prokaryotic Transcriptional Activators and Repressors
Transcription of prokaryotic...